NextCell Pharma AB

NextCell Pharma is an innovative Biotech growing out of the need for Advanced Therapy Medicinal Products for Autoimmune Disease and Transplantation.

[NextCell Pharma AB @NextCellPharma]

Read about our updated growth strategy.
https://t.co/WN9xzfIMJa

[NextCell Pharma AB @NextCellPharma]

Today we were featured in the magazine Diabetes. Read the article (in Swedish) about Elin Cederbrant and Ella Wahlgren discussing type 1 diabetes and being part of a clinical trial with ProTrans.
https://t.co/UZA9uFY2Cj

[NextCell Pharma AB @NextCellPharma]

We have just published our Annual report 2022/2023.
https://t.co/4x3KLt2nOE

[NextCell Pharma AB @NextCellPharma]

Lindsay Davies was extensively interviewed during the Advanced Therapies Europe conference. Here, she contributes to an article.
https://t.co/87I5CqCaap

[NextCell Pharma AB @NextCellPharma]

In September, NextCell's Lindsay Davies delivered a presentation at the Advanced Therapies Europe conference in Portugal, during which she was interviewed by RegMedNet. This interview has been published as an article.
https://t.co/qojnj7jikL

[NextCell Pharma AB @NextCellPharma]

NextCell has signed an agreement with the Finnish biotechnology company Linio to warehouse and distribute Tience® in Sweden.
https://t.co/hnfNCW8Y71

[NextCell Pharma AB @NextCellPharma]

Barnstudien ProTrans Young är hittills den största studien med cellterapiläkemedlet ProTrans från NextCell. Här berättar NextCells VD Mathias Svahn om studien och vilka möjligheter den medför.
https://t.co/oQ8Q85pw3W

[Mathias Svahn @SvahnMathias]

Alla borde anmäla sig som donatorer till Tobiasregistret för att donera stamceller. Bristen på donatorer uppmärksammas i dagens nyhetsmorgon på SVT1 med bilder från NextCells labb.
https://t.co/hnQGcdPVeo

#nextcellpharma #stamceller #stemcells #Cellaviva

[Mathias Svahn @SvahnMathias]

Fortsatt tillstånd från Läkemedelsverket https://t.co/d2VvgNnB5H

[NextCell Pharma AB @NextCellPharma]

Time for an exciting day about ATMPs, business models and health economics

[Mathias Svahn @SvahnMathias]

Promising Results from clinical trial with ProTrans stem cells https://t.co/lfEggQfAmV

[Mathias Svahn @SvahnMathias]

Lovande Resultat från Stamcellsstudie med ProTrans https://t.co/8IZqun59mh

[NextCell Pharma AB @NextCellPharma]

A part of Vision-driven Health

https://t.co/on81Cj4ZmR

[NextCell Pharma AB @NextCellPharma]

En del av projektet Visionsdriven Hälsa

https://t.co/huQ1QforOZ

[Mathias Svahn @SvahnMathias]

Har precis kört ner ”Cellbulansen” till Region Skåne. Konstigt att ett enda landsting motarbetar stamcellssparande trots att lika vård ska gälla oavsett vart i landet man föder. #stamceller #cellaviva #regionskåne #nextcell #nextcellpharma #självbestämmanderättsprincipen

[Mathias Svahn @SvahnMathias]

Nu är det dags för Partnering-middag. Lång dag på #biojapan för #nextcellpharma #nextcell #cellaviva

[Mathias Svahn @SvahnMathias]

ProTrans behandling

[BioM Biotech Cluster Development @BioM_Munich]

Thanks to all participants of the successfull #StartSmartGlobal #Japan workshop! #BioVista #Eukarys @ibidiCells @mecuris @NextCellPharma #Oncgnostics @Oncodesign_SA @parimmune @ScinusCell #therapyselect @EUJapanCentre #sirionbiotech #lifescience #biotech https://t.co/ALD04kcBOE

[NLSDays @NLSDays]

1240 delegates 👩‍🔬👨‍💼
46 company presentations 🗣️
2750 partnering meetings 🤝

These are the numbers that made up #NLSDays2019! for full details and summary of the event, please read our press release: https://t.co/bfcx6CJGs6

[NextCell Pharma AB @NextCellPharma]

Great opportunity to pitch our activities @NLSDays